Change in liver clock could affect synchronization of the circadian cycle

Organisms rely on a biological clock known as the 'circadian' clock to regulate their activity according to the time of day. A central clock, constituted by a group of brain cells -; the suprachiasmatic nuclei, or SCN -; synchronizes the circadian clocks present in all body's organs, called 'peripheral' clocks. Until now, synchronization of the circadian cycle in mammals was thought to be a one-way mechanism in which the suprachiasmatic nuclei alone synchronized the peripheral clocks.

Scientists from CNRS, Université Paris Cité and the University of Queensland, however, in the framework of a joint EU endeavour, have just shown that the liver also influences peripheral clocks. Teams studied a chimeric mouse model with a liver containing human hepatocytes and observed that the daily cycle of these usually nocturnal animals had advanced by two hours.

The mice became active and began feeding two hours before nightfall, thus becoming partly diurnal. The researchers believe this shift comes from the mice's central clock being taken over by the human liver cells in this chimeric animal model. These cells can thus affect the entire rhythmic physiology of the animals, including the clocks of the peripheral organs.

Findings suggest that a change in liver clock -; for example in pathological condition such as cirrhosis -; could affect the synchronition function of the central clock. This in turn could affect the entire circadian physiology, including the sleep/wake cycle, and contribute to the development of metabolic disease. It also suggests that restoring disrupted liver biological rhythm could benefit the entire body metabolism. The hormonal and nervous mechanisms driving this dialogue between the brain, liver and biological clock remain to be identified.



The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
You might also like...
Researchers discover key epigenetic alteration associated with clinical course of liver cancer